|CVS.com Launches Website Clinic on Overactive Bladder - A Condition Affecting One in Five Americans Over Age 45|
WOONSOCKET, R.I., Feb. 8 /PRNewswire/ -- America's #1 pharmacy CVS/pharmacy (NYSE: CVS) today announced it has launched a new condition center on its CVS.com website that provides visitors to the site with easily understood information and tips on how to manage overactive bladder -- a lifestyle-limiting medical condition that affects approximately one out of every five Americans over the age of 45.
This special site, accessible through http://bladder.cvs.com, offers information on a range of topics related to overactive bladder, and is designed to help guide the visitor through simple screening questions to help determine if they are experiencing a bladder control problem. Also provided are suggestions on how to openly discuss overactive bladder symptoms with health care providers and family members, and information on effective therapies available for managing this often disruptive and embarrassing medical condition.
"The CVS.com Overactive Bladder Clinic offers visitors the opportunity to learn more about a prevalent and potentially embarrassing health condition through the privacy and convenience of the Internet," said Doug Callihan, R.Ph, President and CEO of CVS.com. "We encourage anyone who feels that they or their loved ones may be experiencing bladder control problems like overactive bladder to visit our website. Overactive bladder is a treatable medical condition."
The CVS Overactive Bladder Clinic also provides background information on normal bladder function and the various problems that may arise due to other incontinence-related conditions including stress. Patients who have sought medical attention for their bladder conditions may return to the website to fulfill their prescriptions via the CVS.com online pharmacy. Prescription drug therapies such as DETROL(R) LA (tolterodine tartrate extended release capsules) effectively treat the symptoms of overactive bladder. The Clinic is sponsored by Pharmacia Corporation, makers of DETROL LA.
About Overactive Bladder
Overactive bladder is a disruptive, chronic medical condition marked by symptoms of urinary frequency (urinating more than eight times in a 24-hour period, including two or more times a night), urgency (strong and sudden desire to urinate), and urge incontinence (accidental loss of urine caused by a sudden and unstoppable urge to urinate). Many people with overactive bladder mistakenly believe that the condition is an unavoidable part of aging they must learn to live with. As a result, many patients suffer in silence without seeking help.
About DETROL LA
DETROL LA Capsules are a once-daily therapy for the treatment of overactive bladder with symptoms of urinary urge incontinence, urgency, and frequency. DETROL LA Capsules are contraindicated in patients with urinary retention (inability to empty the bladder), gastric retention (delayed emptying of the stomach) or uncontrolled narrow-angle glaucoma. Full prescribing information is available through the CVS Overactive Bladder Clinic or by visiting http://www.detrolLA.com.
CVS is America's #1 pharmacy, dispensing more retail prescriptions in more states than any other pharmacy in the U.S. CVS has created innovative approaches to serve the healthcare needs of all its customers through more than 4,100 CVS/pharmacy stores; CVS Procare, its specialty in pharmacy business; CVS.com, its online pharmacy; and PharmaCare, its pharmacy benefit management company. General information about CVS is available through the company's website, at http://www.CVS.com.
Pharmacia Corporation (NYSE: PHA) is a leading global pharmaceutical company created through the merger of Pharmacia & Upjohn with Monsanto Company and its G.D. Searle unit. Pharmacia has a broad product portfolio, a robust pipeline of new medicines, and an annual investment of more than $2 billion in pharmaceutical research and development. SOURCE CVS
CONTACT: Todd Andrews of CVS, 401-770-5717; or Ginger Hall of MCS, Inc., 800-477-9626, for CVS/